Clinical Trials Directory

Trials / Completed

CompletedNCT06182254

Personalized Perioperative Care Based on Patient Reported Outcomes Measures

Personalized Perioperative Care Based on Patient Reported Outcomes Measures: Randomized Controlled Trial Based on the QoR-15

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
280 (actual)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In the perioperative setting, Patient Reported Outcomes Measures (PROMs) are important for both patients and clinicians. Reliable PROMs, like the Quality Of Recovery 15 (QoR-15) questionnaire, are available for patients experiencing surgery. These PROMs are significantly used as endoints for clinical interventions assessment. These PROMs may also be considered to monitor and assess patient health status as part of enhanced recovery after surgery pathway. However data about the efficacy of PROMs-based perioperative clinical follow up are lacking. The clinical hypothesis is that a PROMs (QoR-15) based perioperative clinical care is more efficient that the usual care non based on the QoR-15.

Detailed description

The study is a multicenter randomized controlled trial comparing 2 groups: * A control group, including the usual conventional follow-up by the surgeon and the attending physician. * An experimental group including, in addition to the usual conventional follow-up, the follow-up by nurses specialized in the evaluation of the PROMs using the french version of the QoR-15 questionnaire.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExperimental group: OPTIMISTIC follow-upfollow-up by nurses specialized in collecting the patient's point of view concerning his or her state of health, in addition to the usual conventional follow-up according to routine care directive interviews carried out preoperatively and at Days 1, 3, 14 and 28 postoperatively (modified QoR-15f score, PROMS...)
OTHERControl group: Usual conventional follow-upusual conventional follow-up according to routine care (modified QoR-15f score will be administered to all patients at visit 0 and Day 35).

Timeline

Start date
2023-04-14
Primary completion
2025-01-23
Completion
2025-01-23
First posted
2023-12-26
Last updated
2025-05-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06182254. Inclusion in this directory is not an endorsement.